ITGB2 and ovarian serous adenocarcinoma: Consistent with the previous findings, the expression of ITGB2 was increased significantly in serous ovarian cancer cells compared to normal ovarian epithelial cells both in protein and mRNA (messenger ribonucleic acid) levels.